VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for ...
The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...
The U.S. Food and Drug Administration has approved a self-injection version of Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for the treatment of adult patients with generalized ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved the ...
Dupixent comes in two forms: a prefilled pen and a prefilled syringe. The Dupixent pen has a hidden needle and automatically injects the drug. The Dupixent syringe has a visible needle and requires ...
Many people living with rheumatoid arthritis (RA) rely on long-term medications to manage joint pain, stiffness, and inflammation. A number of these treatments are given as subcutaneous injections, ...
(MENAFN- GlobeNewsWire - Nasdaq) Global Prefilled Syringes Market Growth is Fueled by Increasing Demand for Biologic Drugs, Expanding Self-Administration Trends, and Advancements in Drug Delivery ...
The MarketWatch News Department was not involved in the creation of this content. Prefilled Syringes Market to Surpass USD 18 Bn by 2031 as Biologics and Self-Injection Devices Drive Adoption, Says ...
Administration, Biologics, and Advanced Drug Delivery Systems Continues to Drive Market ExpansionDelray Beach, FL, May 29, 2026 (GLOBE NEWSWIRE) -- The global prefilled syringes market is projected to ...
Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that ...
Austin, United States, May 14, 2026 (GLOBE NEWSWIRE) -- “According to SNS Insider, the Prefilled Syringes Market size was valued at USD 9.25 billion in 2025 and is expected to reach USD 29.3 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results